Showing results (1391-1400 of 9,902) with videos related to

Sort By:
Pageof 991
Bone Marrow Transplantation|January 1, 1992
Poor prognosis acute myeloid leukaemia treated by matched unrelated donor marrow transplant without preceding total body irradiationE J Kanfer, I Macdonald, G Hall, et al.
Bone Marrow Transplantation|October 27, 2004
How and when should we monitor chimerism after allogeneic stem cell transplantation?P Bader, D Niethammer, A Willasch, et al.
Bone Marrow Transplantation|December 8, 2004
CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimensM Kalaycio, L Rybicki, B Pohlman, et al.
Bone Marrow Transplantation|October 19, 2004
Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host diseaseV T Ho, H T Kim, S Li, et al.
Bone Marrow Transplantation|October 19, 2004
Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphomaD Decaudin, J-M Vantelon, J-H Bourhis, et al.
Bone Marrow Transplantation|October 19, 2004
Autologous/syngeneic stem cell transplantation to treat refractory GvHDJ R Passweg, K Orchard, A Buergi, et al.
Bone Marrow Transplantation|October 19, 2004
Characteristics and outcome of patients developing endocarditis following hematopoietic stem cell transplantationJ Kuruvilla, D L Forrest, J C Lavoie, et al.
Bone Marrow Transplantation|February 16, 2005
High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemiaS S Farag, B J Bolwell, P J Elder, et al.
Bone Marrow Transplantation|February 22, 2005
Outcome of unrelated transplants in patients with multiple myelomaK K Ballen, R King, M Carston, et al.
Bone Marrow Transplantation|November 2, 2004
Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcomeR Zeiser, B Deschler, H Bertz, et al.
Pageof 991